Klement Rainer J, Champ Colin E
Department of Radiotherapy and Radiation Oncology, Leopoldina Hospital Schweinfurt, Gustav-Adolf-Straße 8, 97422, Schweinfurt, Germany,
Cancer Metastasis Rev. 2014 Mar;33(1):217-29. doi: 10.1007/s10555-014-9495-3.
Aggressive tumors typically demonstrate a high glycolytic rate, which results in resistance to radiation therapy and cancer progression via several molecular and physiologic mechanisms. Intriguingly, many of these mechanisms utilize the same molecular pathways that are altered through calorie and/or carbohydrate restriction. Furthermore, poorer prognosis in cancer patients who display a glycolytic phenotype characterized by metabolic alterations, such as obesity and diabetes, is now well established, providing another link between metabolic pathways and cancer progression. We review the possible roles for calorie restriction (CR) and very low carbohydrate ketogenic diets (KDs) in modulating the five R's of radiotherapy to improve the therapeutic window between tumor control and normal tissue complication probability. Important mechanisms we discuss include (1) improved DNA repair in normal, but not tumor cells; (2) inhibition of tumor cell repopulation through modulation of the PI3K-Akt-mTORC1 pathway downstream of insulin and IGF1; (3) redistribution of normal cells into more radioresistant phases of the cell cycle; (4) normalization of the tumor vasculature by targeting hypoxia-inducible factor-1α downstream of the PI3K-Akt-mTOR pathway; (5) increasing the intrinsic radioresistance of normal cells through ketone bodies but decreasing that of tumor cells by targeting glycolysis. These mechanisms are discussed in the framework of animal and human studies, taking into account the commonalities and differences between CR and KDs. We conclude that CR and KDs may act synergistically with radiation therapy for the treatment of cancer patients and provide some guidelines for implementing these dietary interventions into clinical practice.
侵袭性肿瘤通常表现出较高的糖酵解速率,这会通过多种分子和生理机制导致对放射治疗的抗性以及癌症进展。有趣的是,许多这些机制利用的是与热量和/或碳水化合物限制所改变的相同分子途径。此外,现已明确,具有以代谢改变(如肥胖和糖尿病)为特征的糖酵解表型的癌症患者预后较差,这为代谢途径与癌症进展之间提供了另一个联系。我们综述了热量限制(CR)和极低碳水化合物生酮饮食(KDs)在调节放射治疗的五个R方面可能发挥的作用,以改善肿瘤控制与正常组织并发症概率之间的治疗窗口。我们讨论的重要机制包括:(1)改善正常细胞而非肿瘤细胞的DNA修复;(2)通过调节胰岛素和IGF1下游的PI3K-Akt-mTORC1途径抑制肿瘤细胞再增殖;(3)使正常细胞重新分布到细胞周期中更具放射抗性的阶段;(4)通过靶向PI3K-Akt-mTOR途径下游的缺氧诱导因子-1α使肿瘤血管正常化;(5)通过酮体增加正常细胞的内在放射抗性,但通过靶向糖酵解降低肿瘤细胞的内在放射抗性。在动物和人体研究的框架内讨论了这些机制,同时考虑了CR和KDs之间的共性和差异。我们得出结论,CR和KDs可能与放射治疗协同作用来治疗癌症患者,并为将这些饮食干预措施应用于临床实践提供一些指导方针。